Maternal and fetal safety of intravenous immunoglobulin in women with reproductive failure.

Aera HanSung Ki LeeJoon Cheol ParkChan Woo ParkJae Won HanKi Hwan Lee

Published in: American journal of reproductive immunology (New York, N.Y. : 1989) (2021)

IVIG use during pregnancy did not increase obstetric complications and fetal teratogenicity. This study can be an evidence of maternal and fetal safety of IVIG administration during pregnancy.

Keyphrases

birth weight
pregnancy outcomes
pregnant women
risk factors
low dose
weight loss